MagVenture Announces Collaboration with Magnus Medical to Bring the SAINT® Neuromodulation System to Market

"MagVenture's high-performance intermittent theta burst system supports our innovative SAINT therapy, therefore, we are poised to deliver rapid and effective relief to people who suffer from treatment-resistant depression," said Christian Gormsen, President and CEO of Magnus Medical. "This collaboration underscores our commitment to advancing the treatment of neuropsychiatric disorders and changing people's lives." "MagVenture's high-performance intermittent theta burst system supports our...
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

"MagVenture's high-performance intermittent theta burst system supports our innovative SAINT therapy, therefore, we are poised to deliver rapid and effective relief to people who suffer from treatment-resistant depression," said Christian Gormsen, President and CEO of Magnus Medical. "This collaboration underscores our commitment to advancing the treatment of neuropsychiatric disorders and changing people's lives."

Kerry Rome, SVP of Sales and Marketing at MagVenture, Inc. continued, "We are excited to enable the expansion of SAINT across the U.S. powered by MagVenture hardware, as well as installation and service support to ensure customers who offer SAINT will experience the same high-quality and reliable operations for which MagVenture is known."

MagVenture and Magnus Medical will exhibit at the upcoming Clinical TMS Society Annual Meeting in London in June where the SAINT system can be seen firsthand.

About MagVenture

MagVenture Announces Collaboration with Magnus Medical to Bring the SAINT® Neuromodulation System to Market

MagVenture is a private, market-leading manufacturer of non-invasive TMS systems worldwide. Headquartered in Denmark, MagVenture has been pioneering leading-edge TMS solutions for more than 30 years. MagVenture's systems are used for both research and treatment in the fields of psychiatry, neurophysiology, neurology, cognitive neuroscience, and rehabilitation. For more information, visit www.magventure.com

Media inquiries:

Kerry Romekr@magventure.com or Lauren Schultheissls@magventure.com, MagVenture, Inc., +1.888.624.7764

Logo - https://mma.prnewswire.com/media/2402306/Logo_2700_pwide_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/magventure-announces-collaboration-with-magnus-medical-to-bring-the-saint-neuromodulation-system-to-market-302132585.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;